1. Home
  2. SENS vs EMF Comparison

SENS vs EMF Comparison

Compare SENS & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$7.37

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Logo Templeton Emerging Markets Fund

EMF

Templeton Emerging Markets Fund

HOLD

Current Price

$23.85

Market Cap

253.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SENS
EMF
Founded
1996
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Finance/Investors Services
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
301.2M
253.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SENS
EMF
Price
$7.37
$23.85
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$18.38
N/A
AVG Volume (30 Days)
512.8K
42.9K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
6.16%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,389,000.00
N/A
Revenue This Year
$74.15
N/A
Revenue Next Year
$58.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.41
$13.71
52 Week High
$8.75
$24.45

Technical Indicators

Market Signals
Indicator
SENS
EMF
Relative Strength Index (RSI) 62.40 63.30
Support Level $7.35 $21.48
Resistance Level $7.57 $24.37
Average True Range (ATR) 0.46 0.86
MACD 0.06 -0.01
Stochastic Oscillator 78.03 79.10

Price Performance

Historical Comparison
SENS
EMF

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

About EMF Templeton Emerging Markets Fund

Templeton Emerging Markets Fund is a closed-end management investment company that seeks long-term capital appreciation by investing mainly in emerging country equity securities under normal market conditions. It invests across various sectors, including Pharmaceuticals, Beverages, Broadline Retail, Metals & Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, Insurance, Entertainment, and others.

Share on Social Networks: